Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01002014 · ClinicalTrials.gov registry record · NA

Nipple Sparing Mastectomy - Cosmetic Outcomes

A NA study of Breast Cancer and Breast Reconstruction, sponsored by Wake Forest University Health Sciences.

Completed
Registry status
NA
Development phase
75
Enrollment target
1
Study location

NCT01002014 is a NA study of Breast Cancer and Breast Reconstruction that has completed, run by Wake Forest University Health Sciences. The registered enrollment target is 75 participants, below the 2,803-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01002014, a NA study of Breast Cancer and Breast Reconstruction, has completed, sponsored by Wake Forest University Health Sciences.

COMPLETED
Registry status
NA
Development phase
75 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to observe the cosmetic outcomes, patient satisfaction, and complications after skin sparing mastectomy with preservation of the nipple areolar complex.

Interventions

  • PROCEDURE Nipple Sparing Mastectomy

Study Locations (1)

North Carolina

  • Levine Cancer Institute - Charlotte

Trial Details

FieldValue
Enrollment Target 75 participants
Start Date 2009-01-21
Est. Completion 2018-09-20
Phase NA

Sponsor

Wake Forest University Health Sciences

1,140 total trials

What the Registry Record Tells You About NCT01002014

The ClinicalTrials.gov registry entry for NCT01002014 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 75 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,803-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (97% lower). The listed sponsor is Wake Forest University Health Sciences, which has 1,140 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with Breast Cancer appearing as the primary indexed condition, and to 1 intervention - of which Nipple Sparing Mastectomy is the first listed.

NCT01002014 reports 1 study location spanning 1 distinct geographic area - top geographies include North Carolina.

Frequently Asked Questions

What is clinical trial NCT01002014 about?

NCT01002014 is a clinical study titled "Nipple Sparing Mastectomy - Cosmetic Outcomes". The purpose of this study is to observe the cosmetic outcomes, patient satisfaction, and complications after skin sparing mastectomy with preservation of the nipple areolar complex.

What is the current status of trial NCT01002014?

This trial is currently completed. It is a NA study. The enrollment target is 75 participants. The study started on 2009-01-21. Estimated completion is 2018-09-20.

What conditions does trial NCT01002014 study?

This clinical trial studies the following conditions: Breast Cancer, Breast Reconstruction, Cosmesis.

What interventions are being tested in trial NCT01002014?

The interventions under investigation include: Nipple Sparing Mastectomy (PROCEDURE).

Who is sponsoring clinical trial NCT01002014?

This trial is sponsored by Wake Forest University Health Sciences, which has 1,140 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01002014 being conducted?

This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Breast Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.